Jason Shand Robins
Chief Financial Officer · OCULAR THERAPEUTIX, INC
Individual
- 2026
- Jun 12, 2026
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Jason Shand Robins files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Pravin Dugel - $1.94M in OCUL purchases and sales in the last 12 months
- Richard L. Md Lindstrom - $461K in OCUL purchases and sales in the last 12 months
- Namrata Saroj - $278K in OCUL purchases and sales in the last 12 months
- Nadia Waheed - $221K in OCUL purchases and sales in the last 12 months
- Donald Notman - $216K in OCUL purchases and sales in the last 12 months
- Jeffrey S. Heier - $204K in OCUL purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Jason Shand Robins?
Jason Shand Robins is a corporate insider, tracked as Chief Financial Officer of OCULAR THERAPEUTIX, INC (OCUL). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Jason Shand Robins last file a Form 4?
The most recent primary Form 4 on record is dated 12 June 2026, one of 2 filings going back to 2026.
